Table 1.
Genotype | Sex | Age, Mo | Number | Procedure |
---|---|---|---|---|
+/b | M | 22 | 1 | A |
+/b | M | 19 | 1 | A |
+/b | M | 12 | 2 | A, B, C, D |
+/b | M | 9 | 3 | A |
+/b | M | 6 | 1 | A, B, C, D |
+/b | M | 3.5 | 4 | A, B, C, D, G |
+/b | M | 3 | 3 | A, B, C, E, F, G |
b/b | M | 9 | 5 | A |
b/b | M | 6 | 2 | A, B, C, D |
b/b | M | 3.5 | 2 | A, B, C, D, G |
b/b | M | 3 | 1 | A, B, C, E, F, G |
+/b | F | 4 | 3 | A, B, C, D |
+/b | F | 3.5 | 2 | A, B, C, D |
+/b | F | 3 | 3 | A, B, C, E, F, G |
b/b | F | 4 | 3 | A, B, C, D |
b/b | F | 3.5 | 1 | A, B, C, D |
b/b | F | 3 | 3 | A, B, C, E, F, G |
A, hemoglobin and hematocrit, liver qRT-PCR; B, enterocyte qRT-PCR; C, immunoblots; D, para-Phenylenediamine assay; E, ferrozine assay; F, mineral analysis; G, immunohistochemistry analysis.